Basma A N, Heikkila R E, Nicklas W J, Giovanni A, Geller H M
Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway 08854.
J Neurochem. 1990 Sep;55(3):870-7. doi: 10.1111/j.1471-4159.1990.tb04572.x.
The toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine (2'Et-MPTP), and their corresponding pyridinium species was studied in the rat pheochromocytoma PC12 cell line. MPTP and its analogues are known to be metabolized by monoamine oxidase (MAO) to dihydropyridinium intermediates which are further transformed, either enzymatically or spontaneously, into pyridinium species. MAO activity in PC12 cells is almost exclusively of the A form, and 2'Et-MPTP is a good substrate for both MAO-A and MAO-B. In contrast, MPTP is a poor substrate for MAO-A, but a good substrate for MAO-B. 2'Et-MPTP caused considerably more cell death than MPTP in the PC12 cells. However, 1-methyl-4-(2'-ethylphenyl)pyridinium and 1-methyl-4-phenylpyridinium, the corresponding pyridinium species formed from 2'Et-MPTP and MPTP, respectively, were equipotent as toxins. The toxic effects of the tetrahydropyridines and their corresponding pyridiniums were both concentration- and time-dependent. Measurements of the levels of the pyridinium species formed and the remaining tetrahydropyridine in the media indicated that 2'Et-MPTP was converted about five to seven times more readily into its toxic pyridinium species than was MPTP. There was, moreover, an excellent correlation between amount of pyridinium formed and cell death. There was also a parallel between the capacity of clorgyline and pargyline, irreversible MAO inhibitors, to decrease the formation of the pyridinium species and their capacity to protect against the toxic actions of the tetrahydropyridines. These data are consistent with the concept that the MAO-A-dependent formation of the pyridinium species from the tetrahydropyridine is a prerequisite for toxicity in PC12 cells.
在大鼠嗜铬细胞瘤PC12细胞系中研究了1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)、1-甲基-4-(2'-乙基苯基)-1,2,3,6-四氢吡啶(2'Et-MPTP)及其相应吡啶鎓类物质的毒性。已知MPTP及其类似物可被单胺氧化酶(MAO)代谢为二氢吡啶鎓中间体,这些中间体可通过酶促或自发方式进一步转化为吡啶鎓类物质。PC12细胞中的MAO活性几乎完全是A型,并且2'Et-MPTP是MAO-A和MAO-B的良好底物。相比之下,MPTP是MAO-A的不良底物,但却是MAO-B的良好底物。在PC12细胞中,与MPTP相比,2'Et-MPTP导致的细胞死亡要多得多。然而,分别由2'Et-MPTP和MPTP形成的相应吡啶鎓类物质1-甲基-4-(2'-乙基苯基)吡啶鎓和1-甲基-4-苯基吡啶鎓作为毒素具有同等效力。四氢吡啶及其相应吡啶鎓类物质的毒性作用均呈浓度和时间依赖性。对培养基中形成的吡啶鎓类物质水平和剩余四氢吡啶的测量表明,与MPTP相比,2'Et-MPTP转化为其有毒吡啶鎓类物质的速度要快约五到七倍。此外,形成的吡啶鎓量与细胞死亡之间存在极好的相关性。不可逆MAO抑制剂氯吉兰和帕吉林减少吡啶鎓类物质形成的能力与其预防四氢吡啶毒性作用的能力之间也存在平行关系。这些数据与以下概念一致,即从四氢吡啶通过MAO-A依赖性形成吡啶鎓类物质是PC12细胞中毒性的先决条件。